Healthcare Private Equity Activity
PitchBook is the most trusted source for healthcare private equity data, research, and technology. Below are featured healthcare private equity reports, high-level data points and takeaways detailing recent performance trends, significant deals, and analyst outlooks for 2026.
PitchBook provides timely, comprehensive data and unmatched market research tools to help healthcare PE market participants identify the size of the market, its most active firms, and the impact of new technological developments.
Healthcare private equity enters 2026 with a cautiously optimistic outlook: record dry powder, a growing backlog of mature assets and AI‑enabled value-creation opportunities are set to spur greater deal activity, but persistent valuation bifurcation and heightened regulatory scrutiny, especially in healthcare services, remain significant headwinds.
Healthcare private equity at a glance
-
747 healthcare services deals in 2025, +9.6% YoY
-
Healthcare services deal value is down 1.6% YoY. -18% YoY Physician practice management (PPM) deal count
-
Healthcare IT PE deal value reaches $43.4B for 2025,
+23.9% YoY
Clinical trials screener
Filter for companies with clinical trial data and search for trials based on criteria such as sponsor, phase, and intervention type. Track clinical trials status alongside company financials for more efficient due diligence and deal sourcing.
Q4 2025 Healthcare Services Report
H2 2025 Healthcare IT PE Update
Q4 2025 Analyst Note: McDermott Will & Schulte HPE NYC Conference Takeaways
PitchBook Navigator
Unlock new insights and streamline healthcare PE workflows with the power of artificial intelligence and human insights. PitchBook Navigator allows clients to quickly find the data they need, answer complex market questions, and build custom screeners in seconds with a natural language interface.
Get expert insights on healthcare PE deals
PitchBook’s Institutional Research Group publishes dozens of reports daily including market updates, emerging technology coverage, and thematic research, to provide actionable insights from across the full investment cycle. Clients can connect with our team of 60+ analysts to dig deeper into the subjects covered in their reports, gain clarity on specific research data, and discuss their unique coverage areas.